Skip to search formSkip to main contentSkip to account menu

SCH 48461

Known as: SCH-48461 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
beta-Lactams have recently been identified as potent, highly efficacious cholesterol absorption inhibitors (CAIs). The discovery… 
2004
2004
disease (CHD) or atherosclerosis is elevated levels of serum cholesterol. Recent clinical trials and studies have confirmed that… 
Review
2003
Review
2003
OBJECTIVE: To review the primary literature describing the pharmacology of ezetimibe and clinical trials investigating its use in… 
Highly Cited
2002
Highly Cited
2002
Intestinal cholesterol absorption is a major determinant of plasma low density lipoprotein-cholesterol (LDL-C) concentrations… 
2001
2001
SCH 48461, an inhibitor of gastrointestinal absorption of cholesterol, was evaluated for its effects on lipid parameters in… 
1996
1996
Clinical Pharmacology & Therapeutics (1996) 59, 194–194; doi: 10.1038/sj.clpt.1996.274